We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 12 of 201 for:    Recruiting, Not yet recruiting, Available Studies | "Mental Health"

StayOK - an Innovative Measuring Instrument for the Early Identification and Treatment of Psychosocial Risks (StayOK)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03213327
Recruitment Status : Recruiting
First Posted : July 11, 2017
Last Update Posted : July 11, 2017
Sponsor:
Collaborators:
Information provided by (Responsible Party):

June 15, 2017
July 11, 2017
July 11, 2017
July 10, 2017
December 31, 2018   (Final data collection date for primary outcome measure)
  • Psychological distress [ Time Frame: 0 week (first assessment) ]
    The psychological distress is assessed by the Brief Symptom Inventory (BSI; Derogatis & Melisaratos, 1983)
  • Work-related sense of coherence [ Time Frame: 0 weeks ]
    The work-related sense of coherence is assessed by the Work Sense of Coherence (W-SoC 9; Jenny et al., 2016)
  • Perceived self-efficacy [ Time Frame: 0 weeks ]
    This aspect is measure by the General Self-Efficacy Scale (GSE; Damásio et al., 2016)
Same as current
Complete list of historical versions of study NCT03213327 on ClinicalTrials.gov Archive Site
Effectiveness of health-promoting advices [ Time Frame: 12 weeks after the first assessment ]
The effectiveness of the advices generated by the software is assessed by means of a self-developed questionnaire: Participants are inquired as to (1) whether they put in practice the advices and (2) how they evaluate the benefit of the applied advices and the consequent satisfaction.
Same as current
Not Provided
Not Provided
 
StayOK - an Innovative Measuring Instrument for the Early Identification and Treatment of Psychosocial Risks
StayOK - an Innovative Measuring Instrument for the Early Identification and Treatment of Psychosocial Risks
The validity and the sensitivity of different measures implemented in the web application StayOk are investigated. The measures are used primarily for the assessment and the early identification of psychosocial risks. Secondarily, the results of the assessment are applied to generate health-promoting advices for the user of the web application.
Not Provided
Interventional
Not Provided
Intervention Model: Single Group Assignment
Intervention Model Description:

Patients are examined at two time points: baseline and 12 weeks after the Intervention.

The Intervention consists of health-promoting advices provided by the software algorithm. The effect of this intervention is evaluated 12 weeks after.

Masking: None (Open Label)
Primary Purpose: Health Services Research
Mental Health Disorder
Device: StayOk web application
Patients fill in the questionnaires of the web application and receive an analyzed profile of their psychosocial condition and health-promoting advices
Case management
Case management program Utilization of the StayOk web application
Intervention: Device: StayOk web application

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
350
March 31, 2019
December 31, 2018   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • at 16 years of age
  • mild to moderate psychological distress

Exclusion Criteria:

  • serious cognitive impairment due to dementia or cerebrovascular insult
  • Insufficient knowledge of one of the following languages: German, French, Italian or English
Sexes Eligible for Study: All
16 Years to 65 Years   (Child, Adult)
Yes
Contact: Ursula Büsser, MSc +41 79 957 11 58 ursula.buesser@lcc-consulting.ch
Switzerland
 
 
NCT03213327
BASEC-Nr. 2016-00879
Yes
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Plan to Share IPD: No
Aureliano Crameri, Zurich University of Applied Sciences
Zurich University of Applied Sciences
  • LCC
  • Helsana
  • Neomentum
  • Sanatorium Kilchberg AG
  • Design your life
Principal Investigator: Agnes von Wyl, Prof Zurich University of Applied Sciences
Zurich University of Applied Sciences
July 2017

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP